8.59
+0.155(+1.84%)
Currency In USD
| Previous Close | 8.43 |
| Open | 8.42 |
| Day High | 8.63 |
| Day Low | 8.42 |
| 52-Week High | 21.95 |
| 52-Week Low | 4.85 |
| Volume | 7,201 |
| Average Volume | 34,326 |
| Market Cap | 34.73M |
| PE | -0.67 |
| EPS | -12.85 |
| Moving Average 50 Days | 9.6 |
| Moving Average 200 Days | 8.87 |
| Change | 0.16 |
If you invested $1000 in FibroGen, Inc. (FGEN) 10 years ago, it would be worth $11.09 as of December 24, 2025 at a share price of $8.585. Whereas If you bought $1000 worth of FibroGen, Inc. (FGEN) shares 5 years ago, it would be worth $8.5 as of December 24, 2025 at a share price of $8.585.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration
GlobeNewswire Inc.
Dec 15, 2025 12:00 PM GMT
Company is on track to file the Phase 3 protocol in the fourth quarter of 2025 SAN FRANCISCO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Office of Orphan Products Development of the U.S. Food and Drug A
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit
GlobeNewswire Inc.
Dec 02, 2025 9:05 PM GMT
SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the Oppenheimer Movers in Rare Disease Summit being held on December 11, 2025, in New York, NY. Than
FibroGen to Report Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Nov 03, 2025 9:02 PM GMT
SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce third quarter 2025 financial results on Monday, November 10 after market close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern